NASDAQ: ANPCAnpac Bio Medical Science Co Ltd Stock
$6.53-0.05 (-0.76%)
Updated Mar 20, 2023
ANPC Price
$6.53
Fair Value Price
$11.76
Market Cap
$13.49M
52 Week Low
$2.60
52 Week High
$11.99
P/E
-0.49x
P/B
-28.19x
P/S
2.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.28M
Earnings
-$14.04M
Gross Margin
78.6%
Operating Margin
-652.83%
Profit Margin
-635.3%
Debt to Equity
-19.48
Operating Cash Flow
N/A
Beta
0.63
Next Earnings
May 14, 2023
Ex-Dividend
N/A
Next Dividend
N/A
ANPC Overview
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ANPC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ANPC ($6.53) is undervalued by 44.49% relative to our estimate of its Fair Value price of $11.76 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ANPC ($6.53) is significantly undervalued by 44.49% relative to our estimate of its Fair Value price of $11.76 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ANPC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ANPC due diligence checks available for Premium users.
Be the first to know about important ANPC news, forecast changes, insider trades & much more!
ANPC News
Valuation
ANPC fair value
Fair Value of ANPC stock based on Discounted Cash Flow (DCF)
Price
$6.53
Fair Value
$11.76
Undervalued by
44.49%
ANPC ($6.53) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ANPC ($6.53) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ANPC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ANPC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.49x
Industry
16.1x
Market
22.37x
ANPC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-28.19x
Industry
4.81x
ANPC's financial health
Profit margin
Revenue
$888.1k
Net Income
-$3.0M
Profit Margin
-342.7%
ANPC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.2M
Liabilities
$9.0M
Debt to equity
-19.48
ANPC's short-term liabilities ($8.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ANPC's short-term assets ($5.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ANPC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ANPC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ANPC vs Biotech Stocks
Anpac Bio Medical Science Co Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.